awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q50668561-4F1A591E-0231-4B27-89C4-1BF3CB4F1296
Q50668561-4F1A591E-0231-4B27-89C4-1BF3CB4F1296
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50668561-4F1A591E-0231-4B27-89C4-1BF3CB4F1296
Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series.
P2860
Q50668561-4F1A591E-0231-4B27-89C4-1BF3CB4F1296
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50668561-4F1A591E-0231-4B27-89C4-1BF3CB4F1296
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
55f07382d1073a309f52421d23018de35f78f8c0
P2860
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.